0 Commentaires
0 Parts
166 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Human Immunoglobulin (pH4) for Intravenous Injection Market to Hit USD 112.15 Billion by 2032“According to a new report published by Introspective Market Research, Human Immunoglobulin (pH4) for Intravenous Injection Market by Product Type, Application, and Distribution Channel, The Global Human Immunoglobulin (pH4) for Intravenous Injection Market Size Was Valued at USD 60.95 Billion in 2023 and is Projected to Reach USD 112.15 Billion by 2032, Growing at a CAGR of 7.01% From...0 Commentaires 0 Parts 752 Vue 0 Aperçu
-
Impact of Regulatory Changes on the Intravenous Immunoglobulin MarketIVIG Therapy Demand Drivers: What’s Fueling Growth in the Intravenous Immunoglobulin Market Intravenous immunoglobulin (IVIG) therapy has become a cornerstone treatment for a wide range of immune‑mediated conditions, including primary immunodeficiency diseases, autoimmune disorders, and certain neurological conditions. The growing clinical adoption of IVIG therapies has significantly...0 Commentaires 0 Parts 392 Vue 0 Aperçu
-
Innovative Solutions Drive Transformation Across the Intravenous Immunoglobulin MarketGlobal Intravenous Immunoglobulin (IVIG) Market Witnessing Strong Growth The global intravenous immunoglobulin market was valued at USD 12.66 billion in 2023 and is expected to grow at a CAGR of 7.50% during the forecast period. The global intravenous immunoglobulin (IVIG) market is experiencing substantial growth, driven by increasing prevalence of immunodeficiency and autoimmune disorders,...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Revealed: Intravenous Immunoglobulin Market to Experience Steady Expansion Through 2035The Intravenous Immunoglobulin (IVIg) Market is on an upward trajectory, with projections indicating a market size of USD 18.99 billion by 2035. This represents a healthy growth rate, showcasing a compound annual growth rate (CAGR) of 3.96%. As healthcare systems worldwide evolve, the demand for IVIg therapies is increasing among hospitals, which currently dominate the market with a significant...0 Commentaires 0 Parts 225 Vue 0 Aperçu